MyFinsight
Home
Compare
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$748K
EPS
$0.01
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
Research and development expenses
-
-
411*
General and administrative expenses
-
-
455*
Intangible asset and goodwill impairment expenses
-
-
2,420*
Operating loss
-
-
-3,286*
Financial expense (income), net
-
-
14*
Loss before tax expenses
-
-
-3,272*
Research and development expenses
443
473
-
General and administrative expenses
289
266
-
Operating loss
-732
-739
-
Tax expenses
-
-
90*
Financial income, net
-16
14
-
Net loss and comprehensive loss
-748
-725
-3,362
Basic EPS
0.01
0.01
-0.055
Diluted EPS
0.01
0.01
-0.055
Basic Average Shares
60,729,100
60,729,100
60,729,100
Diluted Average Shares
60,729,100
60,729,100
60,729,100
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss and
comprehensive loss
-$748K
Operating loss
-$732K
Financial income, net
-$16K
Research and development
expenses
$443K
General and
administrative expenses
$289K
Buy us a coffee
Revium Rx. (RVRC)
Revium Rx. (RVRC)